As a phosphate-binding agent for use in the control of hyperphospatemia in chronic renal failure patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
